MORE►
novel treatments
Nanoscope Therapeutics SVP of Regulatory and Quality Khandan Baradaran [Photo: Nanoscope]
Nanoscope Therapeutics Appoints SVP of Regulatory and Quality
by Lance Murray | May 17, 2024
Khandan Baradaran, PhD, was most recently VP of regulatory CMC at Ultragenyx Pharmaceutical, a biopharmaceutical company involved in the research and development of novel products for the treatment of rare and ultra-rare genetic diseases.
